GENEVA, July 2 -- T-ONE THERAPEUTICS S.R.L. filed a patent application (IB2025/063107) for “IMMUNE CELLS WITH INHIBITED LINE1 EXPRESSION”. With publication no. WO/2026/133221, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....